Incorporating pharmacogenetics into clinical practice: reality of a new tool in psychiatry.  Practical issues related to medication selection.
Smoller
Jordan W
JW
D000928:Antidepressive Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use; D001189:Aryl Hydrocarbon Hydroxylases / Q000235:genetics; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D005838:Genotype; D006801:Humans; D006899:Mixed Function Oxygenases / Q000235:genetics; D010597:Pharmacogenetics; D011619:Psychotropic Drugs / Q000009:adverse effects / Q000627:therapeutic use*
D000928:Antidepressive Agents; D014150:Antipsychotic Agents; D011619:Psychotropic Drugs; D006899:Mixed Function Oxygenases; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D019389:Cytochrome P-450 CYP2D6